Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-036922
Filing Date
2013-07-17
Accepted
2013-07-17 13:13:11
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c569598_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c569598_4x0.xml 4 3789
  Complete submission text file 0001209191-13-036922.txt   5291
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEI PHARMA, INC. 11975 EL CAMINO REAL, SUITE 101 SAN DIEGO CA 92130
Business Address
Glover Nicholas (Reporting) CIK: 0001578888 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 13972067